Scarica l'app Stockscreener
1.58
1.86%
-0.03
Century Therapeutics Inc Borsa (IPSC) Ultime notizie
Octagon Capital Advisors2026 Investor Profile, Portfolio, Team & Investment Trends - Tracxn
Diabetic mice kept normal blood sugar until the transplant was removed. The study lasted over 11 months. - Stock Titan
Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC) - Seeking Alpha
Century Therapeutics rated speculative Buy on p... - Pluang
A new executive gets the right to buy 800,000 Larimar shares - Stock Titan
Form 144 Century Therapeutics For: 25 September By Investing.com - Investing.com Nigeria
Form 144 Century Therapeutics For: 25 September By Investing.com - Investing.com UK
Form 144 Century Therapeutics For: 25 September By Investing.com - Investing.com India
Russotti Gregory Disposes 2,587 Shares of Century Therapeutics (NASDAQ: IPSC) at $1.93 Each - Kalkine Media
Century Therapeutics SVP Douglas Carr sells $3,199 in shares By Investing.com - Investing.com South Africa
Century Therapeutics SVP Douglas Carr sells $3,199 in shares By Investing.com - Investing.com Australia
Century Therapeutics SVP Douglas Carr sells $3,199 in shares By Investing.com - Investing.com Nigeria
Century Therapeutics SVP Douglas Carr sells $3,199 in shares By Investing.com - Investing.com India
Century Therapeutics CTO Gregory Russotti sells $4,992 in stock - Investing.com
Century Therapeutics CTO Gregory Russotti sells $4,992 in stock By Investing.com - Investing.com UK
Century Therapeutics (IPSC) exec sale covers RSU taxes - Stock Titan
Century Therapeutics (IPSC) insider sale only covers tax withholding - Stock Titan
Century Therapeutics (IPSC) CEO holds 3,633,839 shares after tax move - Stock Titan
Century Therapeutics SVP Douglas Carr sells $3,199 in shares - Investing.com
Century Therapeutics (NASDAQ: IPSC) officer intends $4,994 sale of stock - Stock Titan
Century Therapeutics (NASDAQ: IPSC) officer lines up 1,658-share stock sale - Stock Titan
Century Therapeutics (IPSC) awards 148,000 options vesting over 3 years - Stock Titan
Century Therapeutics Adds Director, Advances Cell Therapy Pipeline - The Globe and Mail
Century Therapeutics' SVP Finance Carr Douglas Sells 254 Shares at $2.05 Each (NASDAQ: IPSC) - Kalkine Media
Century Therapeutics (NASDAQ: IPSC) Insider Russotti Gregory Sells 534 Shares, Retains 511,785 Shares - Kalkine Media
Century Therapeutics SVP sells $520 in stock for tax withholding By Investing.com - Investing.com Australia
Century Therapeutics appoints iECURE CEO Joseph Truitt to board - Bitget
Century Therapeutics Adds Joseph Truitt to Board of Directors - Minichart
Century Therapeutics CEO Brent Pfeiffenberger Withholds Shares for Tax on RSU Vesting - kalkinemedia.com
Century Therapeutics CTO Gregory Russotti Executes Automatic Sale of 534 Shares for Tax Withholding - kalkinemedia.com
Century Therapeutics appoints Joseph Truitt to board By Investing.com - Investing.com Nigeria
Century Therapeutics SVP sells $520 in stock for tax withholding - Investing.com
Century Therapeutics SVP sells $520 in stock for tax withholding By Investing.com - Investing.com Canada
Century Therapeutics SVP sells $520 in stock for tax withholding By Investing.com - Investing.com UK
Century Therapeutics Adds Director, Advances Cell Therapy Pipeline - TipRanks
Century Therapeutics (IPSC) CEO shares withheld for taxes on RSU vesting - Stock Titan
Tax-withholding sale trims Century Therapeutics (NASDAQ: IPSC) insider by 534 shares - Stock Titan
Automatic tax sale leaves Century Therapeutics (NASDAQ: IPSC) SVP with 504,565 shares - Stock Titan
Century Therapeutics appoints Joseph Truitt to board By Investing.com - Investing.com India
Century Therapeutics adds director, sets 2026 trial timelines - Stock Titan
Century Therapeutics appoints Joseph Truitt to board - Investing.com
Century Therapeutics Appoints Joseph Truitt to Board of Directors - Yahoo Finance UK
Century Therapeutics appoints Joseph Truitt to board By Investing.com - Investing.com South Africa
Century Therapeutics (NASDAQ: IPSC) officer plans stock sale partly to cover taxes - Stock Titan
Century (IPSC) Earnings Reading: EPS Beats Its Estimate at the Close; Share Move: The Stock Records a 4.27% Decrease in Latest TradingGuidance vs Actual - vinanet.vn
Century Therapeutics CEO Brent Pfeiffenberger Completes RSU Tax Withholding Share Transaction - Kalkine Media
Century Therapeutics (IPSC) CEO stock withheld for taxes - Stock Titan
Mizuho Securities Maintains Century Therapeutics(IPSC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Century Targets FDA Filing for Diabetes Cell Therapy - MyChesCo
HC Wainwright Issues Pessimistic Forecast for IPSC Earnings - MarketBeat
0.85%
3.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):